Authors:
GUREVITZ O
GOLDFARB A
HOD H
FELDMAN M
SHENKMAN B
VARON D
ELDAR M
INBAL A
Citation: O. Gurevitz et al., RECOMBINANT VON-WILLEBRAND-FACTOR FRAGMENT AR545C INHIBITS PLATELET-AGGREGATION AND ENHANCES THROMBOLYSIS WITH RTPA IN A RABBIT THROMBOSIS MODEL, Arteriosclerosis, thrombosis, and vascular biology, 18(2), 1998, pp. 200-207
Authors:
GUREVITZ O
GOLDFARB A
HOD H
FELDMAN M
SHENKMAN B
VARON D
ELDAR M
INBAL A
Citation: O. Gurevitz et al., RECOMBINANT VWF FRAGMENT AR545C (AR545C) INHIBITS PLATELET-AGGREGATION AND ENHANCES THROMBOLYSIS WITH RTPA IN A RABBIT THROMBOSIS MODEL, Thrombosis and haemostasis, 1997, pp. 24-24
Authors:
INBAL A
KENET G
FREEDMAN JE
MICHELSON AD
BRAND N
LOSCALZO J
Citation: A. Inbal et al., IMPAIRED NO-MEDIATED INHIBITION OF PLATELET-AGGREGATION AND P-SELECTIN EXPRESSION BY PLASMA FROM PATIENTS WITH CHILDHOOD STROKE, Thrombosis and haemostasis, 1997, pp. 1245-1245
Authors:
SALOMOR O
DARDIK R
ZIVELIN A
INBAL A
VARON D
MARTINOWITZ U
MANI A
SELIGSOHN U
Citation: O. Salomor et al., HOMOZYGOUS METHYLENETETRAHYDROFOLATE REDUCTASE THERMOLABILITY (MTHFR-T) IS AN INDEPENDENT RISK FACTOR FOR IDIOPATHIC DEEP-VEIN THROMBOSIS (DVT), Thrombosis and haemostasis, 1997, pp. 2326-2326
Authors:
INBAL A
YEE VC
KORNBROT N
ZIVELIN A
BRENNER B
SELIGSOHN U
Citation: A. Inbal et al., FACTOR-XIII DEFICIENCY DUE TO A LEU660PRO MUTATION IN THE FACTOR-XIIISUBUNIT-A GENE IN 3 UNRELATED PALESTINIAN ARAB FAMILIES, Thrombosis and haemostasis, 77(6), 1997, pp. 1062-1067
Authors:
INBAL A
KENET G
ZIVELIN A
YERMIYAHU T
BRONSTEIN T
SHEINFELD T
TAMARI H
GITEL S
ESHEL G
DUCHEMIN J
AIACH M
SELIGSOHN U
Citation: A. Inbal et al., PURPURA FULMINANS INDUCED BY DISSEMINATED INTRAVASCULAR COAGULATION FOLLOWING INFECTION IN 2 UNRELATED CHILDREN WITH DOUBLE HETEROZYGOSITY FOR FACTOR-V-LEIDEN AND PROTEIN-S DEFICIENCY, Thrombosis and haemostasis, 77(6), 1997, pp. 1086-1089
Authors:
INBAL A
BANK I
ZIVELIN A
VARON D
DARDIK R
SHAPIRO R
ROSENTHAL E
SHENKMAN B
GITEL S
SELIGSOHN U
Citation: A. Inbal et al., ACQUIRED VON-WILLEBRAND DISEASE IN A PATIENT WITH ANGIODYSPLASIA RESULTING FROM IMMUNE-MEDIATED CLEARANCE OF VON-WILLEBRAND-FACTOR, British Journal of Haematology, 96(1), 1997, pp. 179-182
Authors:
MIKKOLA H
YEE V
SEITZ R
INBAL A
MUSZBEK L
LOPACIUK S
SCHILLING F
PALOTIE A
GIANGRANDE P
JONES P
WATSON H
TENGBJORN L
TUSELL J
DEMOERLOOSE P
NIEWENHUIS K
ABGRALL J
BEURRIER P
CARON C
CHABOCHE C
CAPEL P
FONDU P
EBERL W
WENZEL E
Citation: H. Mikkola et al., MOLECULAR-GENETICS OF FACTOR-XIII DEFICIENCY IN EUROPE, Blood, 90(10), 1997, pp. 3154-3154
Authors:
INBAL A
GRIFFIN JH
XU X
FERNANDEZ JA
ZIVELIN A
GITEL S
MARTINOWITZ U
HALKIN H
SELIGSOHN U
Citation: A. Inbal et al., EXTENSIVE VENOUS AND ARTERIAL THROMBOSIS IN A PATIENT WITH FAMILIAL APC RESISTANCE WITHOUT R506Q FACTOR-V MUTATION, Blood, 90(10), 1997, pp. 660-660
Authors:
SALOMON O
ZIVELIN A
DARDIK R
INBAL A
VARON D
MARTINOWITZ U
MANI A
LUBETSKY A
STEINBERG DM
SELIGSOHN U
Citation: O. Salomon et al., RISK ASSESSMENT OF SINGLE, DOUBLE AND TRIPLE PROTHROMBOTIC POLYMORPHISMS IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM, Blood, 90(10), 1997, pp. 1125-1125
Authors:
ENGLENDER T
LATTUADA A
MANNUCCI PM
SADLER JE
INBAL A
Citation: T. Englender et al., ANALYSIS OF ARG834GLN AND VA1902GLU TYPE 2A VON-WILLEBRAND DISEASE MUTATIONS - STUDIES WITH RECOMBINANT VON-WILLEBRAND-FACTOR AND CORRELATION WITH PATIENT CHARACTERISTICS, Blood, 87(7), 1996, pp. 2788-2794
Citation: T. Englender et A. Inbal, FUNCTIONAL-ANALYSIS OF 2 TYPE-2A RECOMBINANT VON-WILLEBRAND-FACTORS (VWF) CONTAINING THE R834Q OR V902E MUTATIONS, Thrombosis and haemostasis, 73(6), 1995, pp. 1159-1159
Authors:
INBAL A
ZIVELIN A
KORNBROT N
BRENNER B
SELIGSOHN U
Citation: A. Inbal et al., A LEU660PRO MUTATION IN THE GENE ENCODING FOR SUBUNIT-A OF FACTOR-XIII IS THE CAUSE OF FACTOR-XIII DEFICIENCY IN 3 UNRELATED ARAB FAMILIES, Thrombosis and haemostasis, 73(6), 1995, pp. 1210-1210
Citation: A. Inbal et al., VERY-LOW FREQUENCY OF NORMANDY TYPE MUTATIONS AMONG TYPE-1 VON-WILLEBRAND DISEASE FAMILIES, Thrombosis and haemostasis, 73(2), 1995, pp. 324-324
Authors:
INBAL A
AVISSAR N
SHAKLAI M
KURITZKY A
SCHEJTER A
BENDAVID E
SHANSKE S
GARTY BZ
Citation: A. Inbal et al., MYOPATHY, LACTIC-ACIDOSIS, AND SIDEROBLASTIC ANEMIA - A NEW SYNDROME, American journal of medical genetics, 55(3), 1995, pp. 372-378
Citation: A. Inbal, ACQUIRED ABNORMALITIES OF COAGULATION - FACTS TO CONSIDER IN PATIENTSWITH UNEXPECTED BLEEDING, Israel journal of medical sciences, 31(7), 1995, pp. 448-449
Authors:
SCHULMAN S
VARON D
MARTINOWITZ U
GITEL S
INBAL A
Citation: S. Schulman et al., TREATMENT WITH CONTINUOUS-INFUSION OF A FACTOR-VIII VON-WILLEBRAND-FACTOR CONCENTRATE (HAEMATE P(R)) FOR SURGERY IN PATIENTS WITH VON-WILLEBRAND DISEASE, Blood, 86(10), 1995, pp. 754-754
Authors:
INBAL A
EPSTEIN O
BLICKSTEIN D
KORNBROT N
BRENNER B
MARTINOWITZ U
Citation: A. Inbal et al., EVALUATION OF SOLVENT DETERGENT-TREATED PLASMA IN THE MANAGEMENT OF PATIENTS WITH HEREDITARY AND ACQUIRED COAGULATION DISORDERS, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 599-604
Authors:
INBAL A
KORNBROT N
HARRISON P
RANDI AM
SADLER JE
Citation: A. Inbal et al., EFFECT OF TYPE IIB VON-WILLEBRAND DISEASE MUTATION ARG(545)CYS ON PLATELET GLYCOPROTEIN IB BINDING-STUDIES WITH RECOMBINANT VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 70(6), 1993, pp. 1058-1062
Authors:
INBAL A
KORNBROT N
HARRISON P
RANDI AM
SADLER JE
Citation: A. Inbal et al., EFFECT OF TYPE-IIB VON-WILLEBRAND DISEASE MUTATION ARG-(545) CYS ON PLATELET GLYCOPROTEIN-IB BINDING - STUDIES WITH RECOMBINANT VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1008-1008
Authors:
INBAL A
ENGLENDER T
KORNBROT N
RANDI AM
CASTAMAN G
MANNUCCI PM
SADLER JE
Citation: A. Inbal et al., IDENTIFICATION OF 3 CANDIDATE MUTATIONS CAUSING TYPE-IIA VON-WILLEBRAND DISEASE USING A RAPID, NONRADIOACTIVE, ALLELE-SPECIFIC HYBRIDIZATION METHOD, Blood, 82(3), 1993, pp. 830-836